Viewing Study NCT06005493


Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2026-01-28 @ 5:37 PM
Study NCT ID: NCT06005493
Status: RECRUITING
Last Update Posted: 2025-09-29
First Post: 2023-06-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
None Gastro-esophageal Junction Cancer View
None Pancreatic Ductal Adenocarcinoma View
None Esophageal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLDN18.2 / Claudin 18.2 View
None CD3 View
None T cell-engaging bi-specific antibody View
None Gastric cancer View
None Gastro-esophageal junction cancer View
None Pancreatic ductal adenocarcinoma View
None Solid tumors View
None AZD5863 View